Indo Borax Acquires 64.26% Stake in Kronox Lab Sciences Amid Complete Board Overhaul
Kronox Lab Sciences Ltd · Outcome · 29 Sept 2026, 10:56 pm
Indo Borax Acquires 64.26% Stake in Kronox Lab Sciences Amid Complete Board Overhaul Promoters of Kronox Lab Sciences transferred a 64.26% stake (2,38,44,000 shares) to Indo Borax & Chemicals on 29th Sep'26, retaining 9.95% and ceding promoter status. Consequently, the company executed a leadership overhaul: outgoing MD Jogindersingh Jaswal, executive directors Ketan Ramani and Pritesh Ramani, and CFO Samir Gadhiya resigned. Suresh Kalra was appointed MD & CEO, and Shashikant Bharuka was named CFO for five-year terms. The three exiting promoters entered 36-month consultancy agreements for transition support, receiving ₹2.10 crore each.
Original exchange filing (PDF)
More announcements from Kronox Lab Sciences Ltd
- The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on November .... · 11 Nov 2026
- The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 10, 2026 for Indo Borax .... · 11 Nov 2026
- The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd · 06 Nov 2026
- The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 05, 2026 for Indo Borax & Chemicals Ltd · 06 Nov 2026
- IIFL Capital Services Ltd (formerly known as IIFL Securities Ltd) ("Manager to the Open Offer") has submitted to BSE a copy of Offer Opening Public Announcement in accordance with Regulation .... · 05 Nov 2026
- Results -Financail Resutls for the Quarter and Half Year ended September 30, 2026 · 05 Nov 2026
- Kronox Lab Sciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 05 Nov 2026
- Outcome of Board Meeting held on Thursday, November 05, 2026 inter to consider and approve unaudited Standalone Financial Results for the Quarter and Half Year ended September 30, 2026 · 05 Nov 2026
